MOVER · WED NOV 4 2026

Why LIVN rose 20.9% on Nov 4 2026: earnings beat

LIVN+20.9%on Wed Nov 4 2026

LivaNova PLC Ordinary Shares was up 20.9% on the day at $96.57, ranked #5 on 37.7× its usual five-minute volume, when TapeRank recorded this spike at 12:18 ET during regular hours.

THE DAY ON THE LIST · 1 EVENT

  1. 12:18 ET
    MOVER · REGULAR

    $96.57 · ▲ 20.9% ON THE DAY · 37.7× 5M RVOL · RANK #5

    STRETCHEDCONFIDENCE5/5

    LivaNova is up 21.0% after a Q3 EPS beat, a 3.2% sales beat, and modestly higher full-year guidance. Those results are clearly positive, but the magnitude of the share-price jump is substantially larger than the quantified earnings and guidance improvements alone support.

    WHYUp 21% on a 16% quarterly EPS beat, 3% sales beat, and modest guidance raise is a move materially larger than the news.
    ANALYZED 12:19 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNA
    THE ROW AND SESSION LEVELS AT 12:18 ET
    LAST96.57
    DAY▲ 20.9%
    5 MIN▼ 1.11%
    5M RVOL37.7×
    5M $VOL$9.4M
    FLOAT*55.1M
    RANK#5
    SESSIONREGULAR
    VWAP94.32
    HOD98.00
    LOD89.50
    OR HIGH94.38
    OR LOW89.50
    PREV CLOSE79.90
    PM HIGH90.21
    PM LOW89.94
    GAP▲ 12.23%

    * FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE

THE SESSION

  • 09:30 ETOpened at $89.67, +12.2% on the previous close of $79.90
  • 09:30 ETRegular-session low, $89.50
  • 13:25 ETRegular-session high, $99.38
  • 15:59 ETLast trade of the regular session, $94.25, +18.0% on the previous close of $79.90
  • Volume: 3.4M shares in regular hours, 20K before the open

LIVN opened at $89.67, dipped to $89.50, and then climbed to a $99.38 high at 13:25 ET before ending the regular session at $94.25, with no halts. TapeRank tied the move to LivaNova’s Q3 adjusted EPS beat, 3.2% sales beat, and modestly higher full-year guidance, while reading the roughly 21% advance as substantially larger than those quantified improvements alone supported. The reported results included adjusted EPS of $1.23 versus a $1.06 estimate, sales of $393.100 million versus $381.067 million, and raised fiscal-year guidance.

WRITTEN WED NOV 4 2026 16:01 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE

FILINGS AND NEWS · 24H BEFORE THE MOVE

On the tape right now

WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY

01
ECGSURGING 0:05
79.71
▼ 29.3%
▼ 1.41%
41.0×
FAD
$6.2M
51.1M*
STRETCHED
02
CAVASURGING 0:00
64.78
▲ 7.4%
▲ 1.30%
9.3×
ORBHODVWH
$11.6M
116.8M*
UNEXPLAINED
03
URGNSURGING 0:00
29.16
▼ 15.2%
▼ 1.29%
15.6×
FAD
$1.4M
48.9M*
JUSTIFIED
04
MPTISURGING 0:00
64.15
▼ 1.5%
▲ 0.96%
23.8×
VWH
$637K
4.3M*
UNEXPLAINED
05
LSPDSURGING 0:00
11.52
▲ 4.9%
▼ 1.24%
16.5×
ORB
$426K
133.3M*
UNEXPLAINED
06
CRCTSURGING 0:00
8.90
▲ 49.2%
▼ 0.72%
15.1×
GAPORBVWHEXT
$395K
54.7M*
STRETCHED
07
BROSSURGING 0:00
43.97
▲ 0.9%
▼ 0.91%
4.0×
FAD
$4.3M
137.9M*
UNEXPLAINED
08
LMRICOOLING 1:35
12.85
▲ 14.5%
▲ 1.06%
132×
ORBHODVWH
$1.7M
—
UNEXPLAINED
Open the full list